Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2178.8000 12.00 (0.55%)
NSE Dec 12, 2025 15:31 PM
Volume: 1.1M
High volume today

logo
Mankind Pharma Ltd.
07 Nov 2025
2178.80
0.55%
Jefferies Keeps Mankind Pharma Among Top Picks Despite Q2 Setback Check Revised Target Price
Jefferies Keeps Mankind Pharma Among Top Picks Despite Q2 Setback Check Revised Target Price
NDTV Profit
Jefferies has trimmed the target price of Mankind Pharma citing a slower-than-expected recovery in its reorganisation efforts.
Geojit BNP Paribas upgraded Mankind Pharma Ltd. to Buy with a price target of 2600.0 on 26 Nov, 2025.
Mankind Pharma Q2 PAT drops 21% on high finance costs; revenue up 20%
Business Standard | 06 Nov 2025
More from Mankind Pharma Ltd.
Recommended
Five Interesting Stocks Today - December 12, 2025
The Baseline | 12 Dec 2025
Market closes higher, supported by a rise in Defence stocks
Trendlyne Marketwatch | 12 Dec 2025
Five stocks to buy from analysts this week - December 11, 2025
The Baseline | 11 Dec 2025